Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, February 25, 2022
Hovione announced that the Board of Directors and the shareholders have approved the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022.
read more
Wednesday, December 27, 2023
Jemincare, a leading pharmaceutical company from China, announced that its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., recently received 6 approvals of clinical trials for its innovative drugs in the field of cancer,...
read more
PaizaBio, Inc. has secured an agreement with Taiwan-based JHL Biotech, Inc. to provide fill-finish services for multiple JHL projects. New Mexico-based PaizaBio will provide these services to JHL through its Hangzhou, China-based strategic partner, ...
read more
Thursday, January 03, 2013
JHP Pharmaceuticals, LLC (“JHP”), a specialty pharmaceutical company that acquires, develops, manufactures and sells sterile injectable products, today announced that it has been acquired by an affiliate of Warburg Pincus, a leading global private ...
read more
Wednesday, April 17, 2013
JHP Pharmaceuticals, a leading provider of global contract manufacturing services for sterile products has entered into an agreement with an undisclosed biotechnology company to produce clinical supplies of a biologic for late-phase clinical trials.
read more
Thursday, September 12, 2019
Zhejiang Jiuzhou has entered into a contractual commitment for the purchase of SNPT, an API manufacturing facility in Suzhou, China.
read more
Wednesday, August 28, 2019
Water Street Healthcare Partners and JLL Partners have acquired THREAD, a provider of technology that enables virtual research approaches to modernize clinical studies and registries.
read more
Veranova, formerly known as Johnson Matthey Health, has launched as an independent company following the acquisition by Altaris Capital Partners, LLC from Johnson Matthey PLC.
Veranova is a global contract development and manufacturing organization ...
read more
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, announced that John Cullivan has joined the Company as a new member of the executive leadership team as Chief Corporate Development ...
read more
Friday, December 20, 2013
In his new role, Ross is responsible for managing and expanding Metrics’ fee-for-service operations. The company’s comprehensive contract services include pharmaceutical oral dose formulation development with dedicated suites for potent product ...
read more
Wednesday, October 14, 2020
Johnson & Johnson announced the EC has approved an Advance Purchase Agreement in which the Janssen will supply 200 million doses of its COVID-19 vaccine candidate to EU Member States following approval or authorization from regulators.
read more
Friday, September 15, 2023
Johnson & Johnson updated its brand and uniting both its medtech and pharmaceutical segments under the Johnson & Johnson brand name to demonstrate its collective power in healthcare.
read more
Wednesday, September 21, 2022
Johnson & Johnson opened its San Francisco Bay Campus, a state-of-the-art Research & Development (R&D) facility in the Bay Area, one of the world’s most established global hubs for innovation and entrepreneurship.
read more
Wednesday, December 03, 2014
Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced completion of an acquisition of pharmaceutical manufacturing capacity in Scotland, U.K. The ...
read more
Tuesday, January 28, 2014
Johnson Matthey Catalysis and Chiral Technologies (JMCCT), a business unit of Johnson Matthey Fine Chemical Division (LSE: JMAT), has announced an expansion to its proprietary tethered catalyst technology, and is now offering multi-kilogram ...
read more